BCAX
Bicara Therapeutics
BCAX
BCAX
113 hedge funds and large institutions have $789M invested in Bicara Therapeutics in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
8% more funds holding
Funds holding: 105 → 113 (+8)
1.82% less ownership
Funds ownership: 93.82% → 92% (-1.8%)
99% less call options, than puts
Call options by funds: $3K | Put options by funds: $350K
Holders
113
Holding in Top 10
9
Calls
$3K
Puts
$350K
Top Buyers
| 1 | +$7.34M | |
| 2 | +$5.12M | |
| 3 | +$4.32M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.96M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.81M |
Top Sellers
| 1 | -$8.82M | |
| 2 | -$6.24M | |
| 3 | -$3.74M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.72M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.49M |
